Bronchial thermoplasty induces immunomodulation with a significant increase in pulmonary CD4+25+ regulatory T cells
- Published on Wednesday, 02 August 2017 14:01
- Written by Juan Carlos Ivancevich
Bronchial thermoplasty (BT) is a method of treating airways and randomized prospective trials have shown positive clinical effects of BT in patients with severe asthma.1 The mechanisms underlying BT airway treatment are not completely understood. Animal and human studies have shown that BT decreases airway smooth muscle mass and contraction.2 Because airway smooth muscle is a source of many proinflammatory factors and mediators, another result of BT could be the attenuation of airway inflammation.
Interasma on Twitter
Interasma RT @Aller_MD: FDA OKs Glaxo's inhaler, first one to combine three medicines https://t.co/KWhVMPYcy6
Interasma RT @Aller_MD: The latest Allergy, Asthma & Immunology! https://t.co/1NJpDoYxrM Thanks to @mnt_allergy @GoAllergy #respiratory #news